ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill

June 27, 1986

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983